Citations

Clear

40 citation(s) found for "Sinclair, Rd".

Surgical management of the recurrent laryngeal nerve in thyroidectomy: American Head and Neck Society Consensus Statement
Fundakowski, Christopher , Hales, Nathan W., Agrawal, Nishant , Camacho, Pauline M., Hartl, Dana M. , Kandil, Emad , Liddy, Whitney , McKenzie, Travis J. , Morris, John C., Schneider, Rick , Serpell, Jonathan W. , Sinclair, Catherine F. , Terris, David J. , Tuttle, R. Michael , Wu, Che‐Wei , Zafereo, Mark , Fundakowski, Christopher E , Barczyński, Marcin , Ridge, John Andrew , Snyder, Susan M. , Wong, Richard J. , Randolph, Gregory William

Mayo Clinic

Head & Neck | February 21, 2018 | Volume: 40 | Issue: 4 | Pages: 663-675

10.1002/hed.24928 | PMID 29461666 Get It

Abstract “I have noticed in operations of this kind, which I have seen performed by others upon the living, and in a number of excisions, which I have myself performed on the dead body, that most of the difficulty in the separation of the tumor has occurred in the region of these ligaments…. This difficulty, I believe, to be a very frequent source of that accident, which so commonly occurs in removal of goiter, I mean division of the recurrent laryngeal nerve.” Sir James Berry (1887)
Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model
Yamamoto, Kazuhiro , Burnett, John C. , Meyer, Linda , Sinclair, L., Stevens, Tracy L., Redfield, Margaret M.

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | December 24, 2017 | Volume: 271 | Issue: 6 | Pages: R1529-R1534

10.1152/ajpregu.1996.271.6.r1529 | PMID 8997349 Get It

his study was designed to characterize left ventricular (LV) function and mass in a modified cardiomyopathy model in the dog in which right ventricular pacing rates are gradually increased throughout 38 days. On the last day of the pacing protocol, ejection fraction was reduced (25 +/- 3 vs. 60 +/- 1%) and LV end-diastolic diameter index (a ratio of LV end-diastolic diameter to body weight, 2.09 +/- 0.02 vs. 1.79 +/- 0.08 mm/kg) and LV mass index (a ratio of LV mass to body weight, 5.2 +/- 0.3 vs. 4.3 +/- 0.2 g/kg) were greater than in the normal dogs (P < 0.05, respectively). Cardiac filling pressures increased, and LV diastolic function and coronary blood flow were impaired. After 4 wk of recovery from the progressive pacing protocol, LV end-diastolic diameter index (2.12 +/- 0.06 mm/kg) and LV mass index (5.6 +/- 0.2 g/kg) remained increased. Ejection fraction was improved (38 +/- 4%) but still depressed. LV diastolic function, coronary blood flow, and cardiac filling pressures returned to levels seen in the normal dogs. This modified cardiomyopathy model associated with LV hypertrophy complements the conventional tachycardia-induced cardiomyopathy model without LV hypertrophy.
Apparent dye-dilution curves produced by injection of transparent solutions
Sinclair, J. D., Sutterer, William F., Fox, Irwin J., Wood, Earl H.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 16 | Issue: 4 | Pages: 669-673

10.1152/jappl.1961.16.4.669 Get It

In studies on dogs, blood was sampled as for the recording of dye-dilution curves through monochromatic densitometers. Injection of hypertonic media into the superior vena cava caused transient increases in the optical density of blood in the pulmonary and femoral arteries so as to produce apparent “dye” curves. The injection of hypotonic and hemolyzing media produced negative deflections, representing decreases in the optical density of blood, as did brief ventilation with 5% and 50% carbon dioxide in oxygen. Similar changes were demonstrated in vitro. They were compensated for in vivo by the use of a dichromatic densitometer. The changes observed are attributed to altered physical properties of the erythrocytes, which consequently change their light-transmitting and light-reflecting characteristics. Such nonspecific changes in the optical density of blood may constitute an important source of error in monochromatic densitometry done on whole blood. Submitted on January 11, 1961
A conserved NAD + binding pocket that regulates protein-protein interactions during aging
Li, Jun , Bonkowski, Michael S. , Moniot, S. , Zhang, Dapeng , Hubbard, Basil P. , Ling, Alvin J. Y. , Rajman, Luis A. , Qin, Bo , Gorbunova, Vera , Aravind, L. , Steegborn, Clemens , Sinclair, David , Sinclair, David A , Lou, Zhenkun

Mayo Clinic

Science | March 23, 2017 | Volume: 355 | Issue: 6331 | Pages: 1312-1317

10.1126/science.aad8242 | PMID 28336669 Get It

NAD + can influence DNA repair by modulating protein interactions.
Accuracy of the ABC/2 Score for Intracerebral Hemorrhage
Webb, Alastair J.S. , Ullman, Natalie , Morgan, Tim C., Muschelli, John , Kornbluth, Joshua , Awad, Issam A. , Rosenblum, Michael , Ziai, Wendy , Zuccarrello, Mario, Aldrich, François, John, Sayona , Harnof, Sagi , Lopez, George Α. , Broaddus, William C. , Wijman, Christine A.C., Vespa, Paul , Bullock, Ross, Haines, Stephen J. , Cruz‐Flores, Salvador , Tuhrim, Stan, Hill, Michael D. , Narayan, Raj K. , Hanley, Daniel F. , Tayal, Ashis , Díaz, Alberto Torres, Hoffer, Alan , Moheet, Asma , Agarwal, Sachin , Markowski, Mason, Rosenthal, Guy , Kureshi, Inam, Varelas, Panayiotis N. , Pinto, Pedro Telles Cougo, Camarata, Paul J. , Helms, Ann , Shahi, Kavian, Sinclair, David, Gizzi, Martin , LeDoux, David, Torbey, Michel , Cockroft, Kevin M. , Antezana, David, Margalit, Nevo, Crabtree, H. Mark, Lovick, Darren, Weaver, Michael, Leonardo, Jody, Ardelt, Agnieszka, Csiba, László , Wartenberg, Katja E. , Bösel, Julian , Adams, Harold P. , Hobohm, Carsten , Kerz, Thomas , Wechsler, Lawrence R. , Gardner, Paul A. , Decker, David A., Gonzales, Nicole R. , Caron, Jean-Louis, Hall, Christiana E., Ansari, Safdar , Luft, Andreas R. , Graham, R. Scott, Tucker, Kristi, Webb, Alastair Js , Mayo, Stephen L. , Martí‐Fábregas, Joan , Seder, David B. , Freeman, William D. , Lazaridis, Christos , LeDoux, David, Latorre, Julius Gene , Venkatasubramanian, Chitra , Jallo, Jack , Reinert, Michael , Butcher, Kenneth , Adeoye, Opeolu M , Testai, Fernando D. , Bulters, Diederik , Caron, Jean-Louis R., Arikán, Fuat , Hill, Michael D , Hanley, Daniel F , Lopez, George

Mayo Clinic

Stroke | August 5, 2015 | Volume: 46 | Issue: 9 | Pages: 2470-2476

10.1161/strokeaha.114.007343 | PMID 26243227 Get It

Background and Purpose— The ABC/2 score estimates intracerebral hemorrhage (ICH) volume, yet validations have been limited by small samples and inappropriate outcome measures. We determined accuracy of the ABC/2 score calculated at a specialized reading center (RC-ABC) or local site (site-ABC) versus the reference-standard computed tomography–based planimetry (CTP). Methods— In Minimally Invasive Surgery Plus Recombinant Tissue-Type Plasminogen Activator for Intracerebral Hemorrhage Evacuation-II (MISTIE-II), Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR-IVH) and CLEAR-III trials. ICH volume was prospectively calculated by CTP, RC-ABC, and site-ABC. Agreement between CTP and ABC/2 was defined as an absolute difference up to 5 mL and relative difference within 20%. Determinants of ABC/2 accuracy were assessed by logistic regression. Results— In 4369 scans from 507 patients, CTP was more strongly correlated with RC-ABC ( r 2 =0.93) than with site-ABC ( r 2 =0.87). Although RC-ABC overestimated CTP-based volume on average (RC-ABC, 15.2 cm 3 ; CTP, 12.7 cm3), agreement was reasonable when categorized into mild, moderate, and severe ICH (κ=0.75; P <0.001). This was consistent with overestimation of ICH volume in 6 of 8 previous studies. Agreement with CTP was greater for RC-ABC (84% within 5 mL; 48% of scans within 20%) than for site-ABC (81% within 5 mL; 41% within 20%). RC-ABC had moderate accuracy for detecting ≥5 mL change in CTP volume between consecutive scans (sensitivity, 0.76; specificity, 0.86) and was more accurate with smaller ICH, thalamic hemorrhage, and homogeneous clots. Conclusions— ABC/2 scores at local or central sites are sufficiently accurate to categorize ICH volume and assess eligibility for the CLEAR-III and MISTIE III studies and moderately accurate for change in ICH volume. However, accuracy decreases with large, irregular, or lobar clots. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: MISTIE-II NCT00224770; CLEAR-III NCT00784134.
Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38
Escande, Carlos , Nin, Verónica , Price, Nathan L. , Capellini, Verena Kise , Gomes, Ana P., Barbosa, Maria Thereza , O’Neil, Luke, White, Thomas A. , Sinclair, David , Chini, Eduardo N. , Sinclair, David A

Mayo Clinic

Diabetes | November 20, 2012 | Volume: 62 | Issue: 4 | Pages: 1084-1093

10.2337/db12-1139 | PMID 23172919 Get It

Metabolic syndrome is a growing health problem worldwide. It is therefore imperative to develop new strategies to treat this pathology. In the past years, the manipulation of NAD+ metabolism has emerged as a plausible strategy to ameliorate metabolic syndrome. In particular, an increase in cellular NAD+ levels has beneficial effects, likely because of the activation of sirtuins. Previously, we reported that CD38 is the primary NAD+ase in mammals. Moreover, CD38 knockout mice have higher NAD+ levels and are protected against obesity and metabolic syndrome. Here, we show that CD38 regulates global protein acetylation through changes in NAD+ levels and sirtuin activity. In addition, we characterize two CD38 inhibitors: quercetin and apigenin. We show that pharmacological inhibition of CD38 results in higher intracellular NAD+ levels and that treatment of cell cultures with apigenin decreases global acetylation as well as the acetylation of p53 and RelA-p65. Finally, apigenin administration to obese mice increases NAD+ levels, decreases global protein acetylation, and improves several aspects of glucose and lipid homeostasis. Our results show that CD38 is a novel pharmacological target to treat metabolic diseases via NAD+-dependent pathways.
Detection and Assessment of Mitral Regurgitation by Left Atrial Indicator-Dilution Curves
Newcombe, C. P., Sinclair, J. D., Donald, David E., Wood, Earl H.

Mayo Clinic

Circulation Research | June 12, 2012 | Volume: 9 | Issue: 6 | Pages: 1196-1207

10.1161/01.res.9.6.1196 | PMID 14479316 Get It

Indicator-dilution curves were recorded simultaneously from the left atrium and the femoral artery during injections of indocyanine green into the left ventricle in normal dogs and in dogs with chronic mitral regurgitation. A study was made-without the use of thoracotomy-of the effect of the following factors on the amount of early appearing indicator detected in the left atrium: (a) the timing of the injection of indicator in relation to the cardiac cycle, (b) the position of the injecting catheter in the left ventricle, and (c) the position of the sampling catheter in the left atrium. It was found that the time and site of the injection into the left ventricle had little effect on the amount of early appearing dye detected in the left atrium and that, although the position of the sampling catheter in the left atrium was important, reproducible results were attained when the sampling site was restricted to a region in close proximity to the mitral valve. A close correlation was demonstrated between the volume of regurgitation determined independently on a hydraulic basis and the volume estimated from the fraction of early appearing indicator detected in the left atrium. It is concluded that further work with this upstream-sampling technique is justified in order to study its possibilities as a practical method for detecting and quantitating mitral regurgitation in human beings.
Combined Intrauterine Vascular Insufficiency and Brachial Plexus Palsy: A Case Report
Murray, Peter M. , TerKonda, Sarvam P. , Sinclair, Catherine F.

Mayo Clinic

HAND | September 20, 2007 | Volume: 3 | Issue: 2 | Pages: 135-138

10.1007/s11552-007-9075-x | PMID 18780089 Get It

A unique case of combined intrauterine vascular insufficiency and complete brachial plexus palsy is described in a newborn delivered by cesarean section. Intrauterine vascular insufficiency resulted in a right below elbow amputation at 3 weeks of age. Amputation length was preserved after a pedicled thoracoabdominal flap. Function of the C5, C6, and C7 nerve roots returned to normal by 3 months of age.
The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet‐induced obesity
Barbosa, Maria Thereza , Soares, Sandra M., Novak, Colleen M. , Sinclair, David , Levine, James , Aksoy, Pınar , Chini, Eduardo N. , Herrmann, Sandra M. , Sinclair, David A , Herrmann, Sandra M

Mayo Clinic

The FASEB Journal | June 21, 2007 | Volume: 21 | Issue: 13 | Pages: 3629-3639

10.1096/fj.07-8290com | PMID 17585054 Get It

ABSTRACT Obesity is one of the major health problems of our times. Elucidating the signaling mechanisms by which high‐fat caloric diet induces obesity is critical for the understanding of this condition and for the development of therapeutic strategies for its treatment. Here, we demonstrate a novel role for protein CD38 as a regulator of body weight during a high‐fat diet. CD38 is a ubiquitous enzyme that catalyzes the synthesis of second messengers and has been implicated in the regulation of a wide variety of signaling pathways. We report that CD38‐deficient mice are pro‐tected against high‐fat diet‐induced obesity owing to enhanced energy expenditure. In fact, calorimetric studies indicate that CD38‐deficient animals have a higher metabolic rate compared to control mice. Analysis of the mechanism revealed that this resistance to diet‐induced obesity is mediated at least in part via a NAD‐dependent activation of SIRT‐PGC1α axis, a well‐established cascade, involved in the regulation of mito‐chondrial biogenesis and energy homeostasis. Thus, together these results identify a novel pathway regulating body weight and clearly show that CD38 is a nearly obligatory component of the cellular cascade that led to diet‐induced obesity.—Barbosa, M. T. P., Soares, S. M., Novak, C. M., Sinclair, D., Levine, J. A., Aksoy, P., Chini, E. N. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet‐induced obesity. FASEB J. 21, 3629–3639 (2007)